Markets:

Overview

News

Currencies

International

Treasuries

Elicio Therapeutics, Inc. - Common Stock (NQ:ELTX)

12.81 +1.03 (+8.74%)

Streaming Delayed Price Updated: 2:21 PM EDT, Apr 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Elicio Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Benzinga's 2024 Virtual Healthcare: What's Next In Health? ↗

March 19, 2024

The 2024 Benzinga Virtual Healthcare Summit brings together top healthcare professionals and companies to discuss industry trends, advancements in technology, and the future of healthcare. Don't miss...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 08, 2024

Via Benzinga

First Patient Dosed In Phase 2 Study Of Elicio Therapeutics’ ELI-002 7P

February 01, 2024

--News Direct--

Via News Direct

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 07, 2024

Via Benzinga

Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy

February 06, 2024

--News Direct--

Via News Direct

Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

February 05, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Elicio Therapeutics Announces Publication Of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy ↗

February 05, 2024

A clinical-stage biotechnology company has published promising preclinical data in Cancer Immunology Research, a journal of the American Association for Cancer Research (AACR).

Via Benzinga

First Patient Dosed In Phase 2 Study Of Elicio Therapeutics' ELI-002 7P ↗

January 31, 2024

A phase 2 trial by a clinical-stage biotechnology company is kicking into full gear.

Via Benzinga

Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002

January 30, 2024

--News Direct--

Via News Direct

Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutics' AMPLIFY-201 Phase 1 Solid Tumor Study Of ELI-002 ↗

January 29, 2024

Colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) are the second and

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 29, 2024

Via Benzinga

Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors

January 25, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 19, 2024

Via Benzinga

Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium

January 17, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference

January 16, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

January 12, 2024

A look at five stocks seeing increased attention from investors.

Via Benzinga

Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study

January 11, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Unity Layoffs 2024: What to Know About the Latest U Job Cuts ↗

January 09, 2024

Unity layoffs are on the way as the video game software company reveals plans to cut 1,800 jobs to focus on its core business.

Via InvestorPlace

Topics Workforce

Why Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today? ↗

January 09, 2024

Cyclacel Pharmaceuticals stock is slipping on Tuesday after shares of CYCC rallied on Monday alongside it regaining Nasdaq compliance.

Via InvestorPlace

Why Is Grifols (GRFS) Stock Down 38% Today? ↗

January 09, 2024

Grifols stock is falling hard as investors sell GRFS shares after the company was hit with a short report from Gotham City Research.

Via InvestorPlace

Why Is Elicio Therapeutics (ELTX) Stock Up 11% Today? ↗

January 09, 2024

Elicio Therapeutics stock is up with heavy trading of ELTX shares are posting positive preliminary results from a Phase 1 clinical trial.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 09, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 09, 2024

Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!

Via InvestorPlace

Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002

January 09, 2024

From Elicio Therapeutics Inc.

Via GlobeNewswire

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 03, 2024

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.